Drug ID: | NPD3615 |
Drug Name: | |
Molecular Formula: | C19H26NO4 |
Canonical SMILES: | OCC(c1ccccc1)C(=O)OC1CC2C3C(C(C1)[N+]2(C)CC)O3 |
Standard InCHI: | InChI=1S/C19H26NO4/c1-3-20(2)15-9-13(10-16(20)18-17(15)24-18)23-19(22)14(11-21)12-7-5-4-6-8-12/h4-8,13-18,21H,3,9-11H2,1-2H3/q+1 |
Standard InCHIKey: | NVOYVOBDTVTBDX-UHFFFAOYSA-N |
Max Developmental Stage: | Approved |
Max Developmental Stage Source: | TTD |
Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient
Tanimoto coefficient is calculated based on PubChem 881-bit substructure fingerprints.
High Similarity Level: Tc>=0.85; Intermediate Similarity Level: 0.7 <= Tc < 0.85; Remote Similarity Level: 0.65 <= Tc < 0.7
TTD | DNAP001573 |
DrugBank | |
ChEMBL | |
IUPHAR/BPS | |
PharmaGKB | |
KEGG Drug | |
PubChem CID | 34875 |
ChEBI | |
CAS Number |
Molecular Weight | 332.19 |
ALogP | -2.6555 |
MLogP | 3 |
XLogP | 2.728 |
HDA | 4 |
HBD | 1 |
Rotatable Bonds | 9 |
TPSA | 59.06 |
RO5 Violation | 0 |